Report Summary

Pain Therapeutics, Inc. Company Profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Pain Therapeutics is a biopharmaceutical company that develops novel drugs for pain management and oncology. The company has three investigational drug candidates in the clinical programs, namely: Remoxy, PTI-202 and Oxytrex. The company is also developing a novel radio-labeled monoclonal antibody to treat metastatic melanoma, a rare but deadly form of skin cancer. Pain Therapeutics is headquartered in San Francisco, California and employed 41 people as of December 2006. The company recorded revenues of $54 million during the fiscal year ended December 2006, as compared to the revenues of $5 million in 2005. The increase in the revenues during the fiscal year 2006 was primarily due to increase in program fee and collaboration revenues in connection with the company’s strategic alliance with King Pharmaceuticals. The operating loss of the company was $0.6 million during fiscal year 2006, as compared to an operating loss of $33 million in 2005. The net profit was $6 million in fiscal year 2006, as compared to a net loss of $31 million in 2005. 10k pg 18, 49

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available